David P. Meeker
President and CEO, Director · RHYTHM PHARMACEUTICALS, INC.
- 2026
- Sep 14, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David P. Meeker files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer Kayden Lee - $8.90M in RYTM purchases and sales in the last 12 months
- Hunter C. Smith - $8.84M in RYTM purchases and sales in the last 12 months
- Yann Mazabraud - $6.62M in RYTM purchases and sales in the last 12 months
- Lynn A. Tetrault - $3.71M in RYTM purchases and sales in the last 12 months
- Joseph Shulman - $3.67M in RYTM purchases and sales in the last 12 months
- Pamela J. Cramer - $2.62M in RYTM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David P. Meeker?
David P. Meeker is a corporate insider, tracked as President and CEO, Director of RHYTHM PHARMACEUTICALS, INC. (RYTM). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David P. Meeker submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has David P. Meeker been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($5.13M) across all tracked filings.
